Diseases associated with human papillomavirus: from understanding of etiopathogenesis to prevention and rational management tactics

The purpose: to consider modern concepts of epidemiology, biological characteristics, pathogenesis, clinical manifestations, principles of therapy and prevention of human papillomavirus infection.

Basic provisions. In the last decade, there has been a steady increase in diseases associated with the human papillomavirus (HPV). The prevalence of human papillomavirus infection of the genitals in the world has increased more than 10 times, it is found in 13 % of the population. Cervical cancer remains one of the most common forms of HPV-associated malignancy in women. About 570 thousand new cases of cervical cancer are diagnosed in the world every year, while the increase in incidence over the past 10 years was 7.8 %, and mortality was 13.1 %. In recent years, scientists have paid close attention to the study of assessing the effect of HPV on the endometrium and the degree of its participation in the development of GGE. From the standpoint of the latest scientific data, the generality of the influence of HPV on any epithelium should be considered through the prism of squamous cell metaplasia. Currently, there are still many unsolved scientific and practical issues, primarily related to the regional characteristics of the prevalence of various types of HPV, which determines the direction of cervical screening, as well as clinical manifestations during coinfection, dictating the need for a differentiated approach to patient management tactics.

Conclusion. A review of modern literature data indicates that most studies on various aspects of the influence of HPV on the reproductive health of women remain the subject of discussion, which dictates the need for further research.

1. Abakarova PR, Prilepskaya VN. HPV-associated diseases of cervix. Complex therapy options. Gynecology. 2017; 5: 4-9. (In Russian)

2. Tikhomirov AL, Sarsaniya SI, Filatova GA. Human papilloma virus: from understanding of immunopathogenesis to rational tactics of management. Gynecology. 2018; 3: 5-11. (In Russian)

3. Kiselev VI, Muyzhnek EL, Ashraphyan LA, Sukhikh GT. A new paradigm in cervical neoplasia progression: from fundamental knowledge to practical gynecology. Obstetrics and Gynecology. 2019; 1: 5-12. (In Russian)

4. Tang Y, Zheng L, Yang S et al. Epidemiology and genotype distribution of human papillomavirus (HPV) in Southwest China: a cross-sectional five years study in non-vaccinated women. Virol J 2017; 14: 84.

5. Rogovskoya SI, Lipova EV. Cervix, vagina, vulva. Physiology, pathology, aesthetic correctyion: a guide for practitioners. M.: Status Praesens, 2016; 832. (In Russian)

6. Kaprin AD, Starinskiy VV, Petrova GV. Malignant neoplasms in Russia in 2017 (morbiliti and mortality). М.: Moscow Research Institute n. a. P. A. Herzen - a Branch of the National Medical Radiological Research Centre, 2018, 250. (In Russian)

7. Mittal S, Banks L. Molecular mechanisms underlying human papillomavirus E 6 and E 7 oncoprotein-includid cell transformation. Mutat. Res. 2017; 772: 23-35.

8. Andersen AS, Koldiaer Solling AS, Ovesen T. et al. The interplay between HPV and host immunity in head and neck squamous cell carcinoma. Int J Cancer 2014; 134 (12): 2755-63.

9. Hong S, Laimomis A, Laimins. Manipulation of innate immune response by human papillomavirusses. Shiyuan Virus Res 2017; 231: 34-40.

10. Lowy DR. HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic scince to effective interventions. J Clin Invest 2016; 126 (1): 5-11.

11. Chernukha GE, Dumanovskaya MR. Current understanding of endometrial hyperplasif (literature rewiew). Obstetrics and Gynecology. 2013; 3: 26-32. (In Russian)

12. Radzinskiy VE, Ordiyants IM, Dobretsova TA. Endometrium on fire. Acute and chronic inflammation of the endometrium: from new perspectives to new strategies. Status Praesens. Gynecology, obstetrics barren marriage. 2016; 2: 126-132. (In Russian)

13. Tkachenko LV, Sviridova NI. Two-step method for the treatment of chronic endometritis in women with endometrial hyperplastic processes in perimenopause. Gynecology. 2016; 1, 40-44. (In Russian)

14. Dikke GB, Ostromenskiy VV. Violation of the immune status in chronic endometritis fnd the experience of its correction through local cytokine therapy. Obstetrics and gynecology. 2019; 9: 139-146. (In Russian)

15. Levakov SA, Sheshukova NA, Kedrova AG, Fedotova AS, Obukhova EA. Molecular biological profiles of endometrial hyperplasia and endometrial intraepithelial neoplasia. Tumors of the female reproductive system. 2018; 2: 76-81. (In Russian)

16. Davydov AI, Shakhlamova MN, Lebedev VA. Cervical intraepithelial neoplasia associated with papillomavirus infection: pathogenetic rationale of treating patients during the reproductive period. Vopr. ginecol. akush. perinatol. (Gynecology, Obstetrics and Perinatology). 2018; 17 (3): 66-72. (In Russian)

17. Davydov AI, Shakhlamova MN, Lebedev VA. Surgical and post-operative treatment of cervical pathology associated with human papillomavirus. Vopr. ginecol. akush. perinatol. (Gynecology, Obstetrics and Perinatology). 2019; 18 (1): 11-19. (In Russian)

18. Clinical Guidelines ‘Cervical intraepithelial neoplasia, erosion and ectropion of the cervix'. Moscow. 2020; 59 p. (In Russian)